Clinical trial Recruiting at 1 site Interventional Ages 21 to 85

Surgify Halo™ versus Rosen burr for cutting performance and usability in spine surgery

Official title: An Open, Parallel-group, Randomized, Medical Device Study to Assess the Usability and Performance of Surgify HaloTM in Spine Surgery Versus State-of-art (Rosen Burr)

Run by Surgify Medical Oy · NCT06827795 · Data updated 2026-11-12

This will test whether the Surgify Halo™ device cuts bone with less chattering and better usability than a standard Rosen burr for adults having spine surgery.

More Spine Surgery trials

Quick facts

Study typeInterventional
Ages21 Years to 85 Years
SexAll
Enrollment30 (estimated)
SponsorSurgify Medical Oy
Industry-sponsored
Locations1 site (New York, New York)
StatusRecruiting
StartedFebruary 19, 2026
Main results expectedDecember 15, 2026
Study endsDecember 31, 2026
Registry record updatedApril 30, 2026
Trial IDNCT06827795 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 21–85 with spine disease requiring surgery with bone removal who can give informed consent are suitable candidates.

Probably not a fit

Patients with abnormal bone tissue, known allergy to medical-grade stainless steel or alloy components, bleeding or clotting problems, pregnant women, or other excluded vulnerable populations are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a randomized, open-label, parallel-group comparison enrolling about 30 adult patients undergoing spine surgery that requires bone removal. Participants will be randomly assigned to have bone work performed with the Surgify Halo™ device or with the conventional Rosen burr, and surgeons will record usability and performance metrics during the procedures. Key outcomes include amount of chattering during use, cutting performance, and surgeon-rated usability, with safety monitoring for device-related issues. The device is intended for shaping and removal of hard tissue and bone and will be used in a single-center surgical setting at North Shore University Hospital.

Why it matters

Potential benefit: If successful, the Surgify Halo™ could reduce tool chattering and improve cutting precision and surgeon handling, potentially making certain spine procedures quicker or safer.

How similar studies have gone: Other novel bone-cutting and burr designs have shown mixed results in improving cutting efficiency and surgeon experience, and this specific device has limited comparative published data.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Disease of the spine requiring surgery with bone removal

  * Ability to understand the purpose and risks of the study and to give written informed consent
  * Age 21-85 years

Exclusion Criteria:

* Abnormalities of bone tissue
* Vulnerable patients (such as prisoners, Individuals with limited or no reading skills, decisionally impaired persons, persons in nursing homes, patients in emergency), and pregnant women
* Allergy or hypersensitivity to medical-grade stainless steel or any alloying components
* Problems with blood clotting

Where it's running

  • North Shore University Hospital
    New York, New York, United States
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.